GSK199

CAS No. 1549811-53-1

GSK199( —— )

Catalog No. M23670 CAS No. 1549811-53-1

GSK199 is a selective PAD4 inhibitor(IC50 of 200 nM in the absence of calcium).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 159 In Stock
5MG 136 In Stock
10MG 226 In Stock
25MG 371 In Stock
50MG 510 In Stock
100MG 686 In Stock
200MG 923 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK199
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK199 is a selective PAD4 inhibitor(IC50 of 200 nM in the absence of calcium).
  • Description
    GSK199 is a selective PAD4 inhibitor(IC50 of 200 nM in the absence of calcium).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PAD4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1549811-53-1
  • Formula Weight
    469
  • Molecular Formula
    C24H29ClN6O2?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CCN1C(=CC2=C1N=CC=C2)C3=NC4=C(N3C)C(=CC(=C4)C(=O)N5CCC[C@H](C5)N)OC.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Willis V C , Banda N K , Cordova K N , et al. Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis[J]. Clinical & Experimental Immunology, 2017.
molnova catalog
related products
  • Isophorone(b)

    Isophorone is a clear liquid that smells like peppermint. It can be dissolved in water and evaporates somewhat faster than water.?

  • Mitoquidone

    Mitoquidone, a novel pentacyclic pyrroloquinone, is a potential anticancer agent. Mitoquidone showed good activity in a range of experimental solid tumour models and did not exhibit significant cytotoxicity.

  • N-(2,6-dioxopiperidi...

    N-(2,6-dioxopiperidin-3-yl)-4-nitrophthalimide exhibit inhibition of CRBN.